Patient Perspectives on the Value of Patient Preference Information in Regulatory Decision Making: A Qualitative Study in Swedish Patients with Rheumatoid Arthritis.

Karin Schölin BywallJorien VeldwijkMats G HanssonUlrik Kihlbom

Published in: The patient (2020)

Patients thought PPI could be valuable to consider in regulatory decisions. It is essential for patients to be well-informed when asked for their preferences. Research on information materials to inform patients in preference studies is needed to increase the value of PPI in regulatory decision making.

Keyphrases

end stage renal disease
decision making
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
small molecule
patient reported outcomes
patient reported